Avanos Medical Inc (AVNS)

Avanos Medical Inc. is a healthcare equipment and supplies company listed on the New York Stock Exchange under the ticker AVNS. The company develops medical device solutions used across North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. Its product portfolio includes digestive health products such as enteral feeding and neonatal or pediatric feeding systems, as well as non-opioid pain management solutions that include surgical pain pumps and cold and compression therapy systems. Avanos also provides interventional pain products designed for minimally invasive treatment of chronic pain. The company sells to hospitals, healthcare providers, healthcare facilities, and other customers directly and through wholesale distributors. Formerly known as Halyard Health, Inc., it adopted the Avanos Medical name in June 2018. The company was incorporated in 2014 and is based in Alpharetta, Georgia.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Analyst Price Target Analyst Target Upside/Downside Price-to-Book Ratio Price-to-Sales Ratio Market Cap Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NYSE-AVNS
Not available
Not available
Not available
1.5x
1.6x
1.171 B
10.6%
98.3%
2.5
-10.1%
Valuation • Fair Value

Avanos Medical Inc (NYSE-AVNS) Fair Value by Valuation Model

No usable valuation estimate is currently available for Avanos Medical Inc (NYSE-AVNS); fair value and analyst target coverage statuses are shown explicitly below.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

No usable valuation estimate is currently available for Avanos Medical Inc (NYSE-AVNS). Fair value and the analyst target remain visible as coverage-status fields and should not be read as valuation signals while unavailable.

Profitability • Growth

Profitability & Growth for Avanos Medical Inc (NYSE-AVNS)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

715.9 M

Current operating scale indicator.

Revenue Forecast

710 M

Forward revenue estimate.

EBITDA

55.9 M

Current operating profitability reference.

EBITDA Forecast

163.7 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Avanos Medical Inc (NYSE-AVNS) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Avanos Medical Inc (NYSE-AVNS)

Review the financial quality and risk indicators currently supported by the latest data.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

-2.93

No elevated caution signal from this screen.

Altman Z-Score

2.5

Intermediate risk zone.

FCF / Net Income

-10.1%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Avanos Medical Inc (NYSE-AVNS). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Avanos Medical Inc (NYSE-AVNS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Avanos Medical Inc (NYSE-AVNS) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Avanos Medical Inc (NYSE-AVNS) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Avanos Medical Inc (NYSE-AVNS) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Avanos Medical Inc (NYSE-AVNS) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ Fast Investor Answers

Avanos Medical Inc (NYSE-AVNS) Stock FAQ

Data-supported answers about Avanos Medical Inc (NYSE-AVNS), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
Not available
No reliable estimate from the currently supported inputs

A reliable fair value estimate is not currently available for Avanos Medical Inc (NYSE-AVNS). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

The current market capitalization listed for Avanos Medical Inc is 1.171 B.

The ticker symbol for Avanos Medical Inc is NYSE-AVNS, and the stock is listed on NYSE.

Avanos Medical Inc (NYSE-AVNS) is listed on NYSE.

The current debt-to-total-capital ratio listed for Avanos Medical Inc is 10.6%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Avanos Medical Inc is 98.3%. Free float helps investors understand how much of the share base is available for public trading.